Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Autoimmunity|March 2, 2010
The type I interferon system in idiopathic inflammatory myopathiesIngrid E Lundberg, Sevim Barbasso Helmers
Arthritis Research & Therapy|October 11, 2014
Expression of BAFF receptors in muscle tissue of myositis patients with anti-Jo-1 or anti-Ro52/anti-Ro60 autoantibodiesOlga Kryštůfková, Sevim Barbasso Helmers, Paulius Venalis, et al.
Annals of the Rheumatic Diseases|February 6, 2007
Limited effects of high-dose intravenous immunoglobulin (IVIG) treatment on molecular expression in muscle tissue of patients with inflammatory myopathiesSevim Barbasso Helmers, Maryam Dastmalchi, Helene Alexanderson, et al.
Arthritis and Rheumatism|September 1, 2007
A possible mechanism for endogenous activation of the type I interferon system in myositis patients with anti-Jo-1 or anti-Ro 52/anti-Ro 60 autoantibodiesMaija-Leena Eloranta, Sevim Barbasso Helmers, Ann-Kristin Ulfgren, et al.
Autoimmunity Reviews|March 17, 2009
Use of a commercial line blot assay as a screening test for autoantibodies in inflammatory myopathiesJohan Rönnelid, Sevim Barbasso Helmers, Helena Storfors, et al.
RMD Open|January 27, 2017
Inflammatory lung disease a potential risk factor for onset of idiopathic inflammatory myopathies: results from a pilot studySevim Barbasso Helmers, Xia Jiang, David Pettersson, et al.
Rheumatology (Oxford, England)|August 14, 2018
Expression of interleukin-18 in muscle tissue of patients with polymyositis or dermatomyositis and effects of conventional immunosuppressive treatmentSevim Barbasso Helmers, Mei Bruton, Ingela Loell, et al.
Annals of the Rheumatic Diseases|September 21, 2012
Low serum levels of vitamin D in idiopathic inflammatory myopathiesPayam Azali, Sevim Barbasso Helmers, Ingrid Kockum, et al.
Pageof 2